Priscilla Velentgas

Summary

Affiliation: Cancer Prevention Program
Country: USA

Publications

  1. ncbi request reprint Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other non-aspirin non-steroidal anti-inflammatory medications
    Priscilla Velentgas
    Ingenix i3 Drug Safety, Auburndale, MA 02466, USA
    Pharmacoepidemiol Drug Saf 15:641-52. 2006
  2. ncbi request reprint Severe vascular events in migraine patients
    Priscilla Velentgas
    Ingenix Epidemiology, Auburndale, MA 02466, USA
    Headache 44:642-51. 2004

Detail Information

Publications2

  1. ncbi request reprint Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other non-aspirin non-steroidal anti-inflammatory medications
    Priscilla Velentgas
    Ingenix i3 Drug Safety, Auburndale, MA 02466, USA
    Pharmacoepidemiol Drug Saf 15:641-52. 2006
    ..The purpose of this study was to estimate rates of acute coronary syndrome (ACS), and sudden cardiac death in relation to use of rofecoxib, celecoxib, naproxen, diclofenac, and ibuprofen...
  2. ncbi request reprint Severe vascular events in migraine patients
    Priscilla Velentgas
    Ingenix Epidemiology, Auburndale, MA 02466, USA
    Headache 44:642-51. 2004
    ..To estimate rates of vascular events in relation to dispensing of triptans and ergot alkaloids among migraineurs, and to compare these rates with those of nonmigraineurs...